246 Infos zu Günter Fingerle-rowson

16 Aktuelle Nachrichten

vor 1 Tag — ... Günter Fingerle-Rowson, MD, PhD, Chief Medical Officer von Tubulis. Der von der FDA gewährte Fast-Track-Status soll die Entwicklung ...

— Tubulis today announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and — Tubulis today announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and ...

MUNICH, GERMANY, April 20, 2021– Tubulis, today announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and to further build the company’s clinical expertise. Dr. Fingerle-Rowson is an experienced

— “ Das Tubulis-Management-Team v.l.n.r.: CMO Dr. Günter Fingerle-Rowson, MD, CSO Dr. Jonas Helma-Smets, CEO Dr. Dominik Schumacher, CBO Dr — “ Das Tubulis-Management-Team v.l.n.r.: CMO Dr. Günter Fingerle-Rowson, MD, CSO Dr. Jonas Helma-Smets, CEO Dr. Dominik Schumacher, CBO Dr ...

9 Profile in Sozialen Netzwerken

Günter Fingerle-Rowson · Chief Medical Officer at Tubulis GmbH · Melden · Melden · Info · Aktivitäten · Berufserfahrung · Ausbildung · Weitere Aktivitäten von Günter ...

Paparan Günter Fingerle-Rowson. Lihat profil Günter Fingerle-Rowson · Günter Fingerle-Rowson. Chief Medical Officer at Tubulis GmbH.

Günter Fingerle-Rowson's Post. View profile for Günter Fingerle-Rowson · Günter Fingerle-Rowson. Chief Medical Officer at Tubulis GmbH.

WebGünter Fingerle-Rowson früher aus Grafing in Bayern hat folgende Schule besucht: von bis Gymnasium Grafing zeitgleich mit Thomas Schmidt und weiteren …

8 Hobbys & Interessen

B., Marek Trněný, M.D., Michael Wenger, M.D., Günter Fingerle-Rowson, M.D., Ph.D., Kaspar Rufibach, Ph.D., Tom Moore, M.B., Ch.B., Michael Herold, M.D., and ... B., Marek Trněný, M.D., Michael Wenger, M.D., Günter Fingerle-Rowson, M.D., Ph.D., Kaspar Rufibach, Ph.D., Tom Moore, M.B., Ch.B., Michael Herold, M.D., and ...

... Günter Fingerle-Rowson, MD, Prof Bruce D Cheson, MD. The Lancet Oncology. Volume 17 Issue 8 Pages (August 2016). DOI: S (16) Günter Fingerle-Rowson, MD, Prof Bruce D Cheson, MD. The Lancet Oncology. Volume 17 Issue 8 Pages (August 2016). DOI: S (16)

20. Apr · Tubulis today announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and to further.

... Günter Fingerle-Rowson, MD, Bruce D Cheson, ProfMD. a British Columbia Cancer Agency, Vancouver, BC, Canada. b University of British Columbia, Vancouver Günter Fingerle-Rowson, MD, Bruce D Cheson, ProfMD. a British Columbia Cancer Agency, Vancouver, BC, Canada. b University of British Columbia, Vancouver ...

3 Business-Profile

Günter Fingerle-Rowson, Basel Berufserfahrung, Kontaktdaten, Portfolio und weitere Infos: Erfahr mehr – oder kontaktier Günter Fingerle-Rowson direkt bei XING.

Günter Fingerle-Rowson CD74 is a surface protein expressed on immune cells, which acts as receptor for the chemokine macrophage migration inhibitory factor (MIF).

Günter Fingerle-Rowson. Unlabelled: Survival of chronic lymphocytic leukemia (CLL) cells depends on stimuli provided by a suitable ... Günter Fingerle-Rowson. Unlabelled: Survival of chronic lymphocytic leukemia (CLL) cells depends on stimuli provided by a suitable ...

1 Firmen-Mitarbeiter

About us · Team · Supervisory Board · Scientific Advisory Board · Technology · Pipeline · Investors · Career · News & Events · Contact us. About us · Team · Supervisory Board · Scientific Advisory Board · Technology · Pipeline · Investors · Career · News & Events · Contact us.

2 Persönliche Webseiten

To contact Günter Fingerle-Rowson send an email to or .

15 Bücher zum Namen

von A Nemajerova · · Zitiert von: 51 — ,. Ute M. Moll. ,. Oleksi Petrenko. &. Günter Fingerle-Rowson. Pages | Published online: 01 May Cite this article · https://doi.org cc. von A Nemajerova · · Zitiert von: 51 — ,. Ute M. Moll. ,. Oleksi Petrenko. &. Günter Fingerle-Rowson. Pages | Published online: 01 May Cite this article · https://doi.org cc.

... Günter Fingerle-Rowson, and Oliver W Press “Randomized Phase II Trial Comparing Obinutuzumab (GA101) with Rituximab in Patients with Relapsed CD20+ ...

Günter Fingerle-Rowson is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Obinutuzumab & Follicular ...

... Ekkehard Mössner, Marina Bacac, Günter Fingerle-Rowson, and Pablo Umaña Introduction 245 Preclinical Experience with Obinutuzumab 246 Characteristics ...

33 Dokumente

von A Hermanowski-Vosatka · · Zitiert von: 135 — ... Maor Sauler, Marta Piecychna, Georgios Pantouris, Elias Lolis, Lin Leng, Jürgen Bernhagen, Günter Fingerle-Rowson, Richard Bucala.

von O Al‐Sawaf · · Zitiert von: 7 — ... Günter Fingerle-Rowson,. Günter Fingerle-Rowson. F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers by this author · Stephan ... von O Al‐Sawaf · · Zitiert von: 7 — ... Günter Fingerle-Rowson,. Günter Fingerle-Rowson. F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers by this author · Stephan ...

— Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs. MUNICH ...

von C Klein · · Zitiert von: 1 — Günter Fingerle-Rowson,. Günter Fingerle-Rowson. Pharma Development Oncology, F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers ... von C Klein · · Zitiert von: 1 — Günter Fingerle-Rowson,. Günter Fingerle-Rowson. Pharma Development Oncology, F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers ...

15 Wissenschaftliche Publikationen

WebPrivatdozent Dr. Günter Fingerle-Rowson, Klinik für Innere Medizin I: Onkologie, Hämatologie, Klinische Infektiologie, Klinische Immunologie, Hämostaseologie, …

von G Fingerle-Rowson · · Zitiert von: 48 — MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Günter Fingerle-Rowson &; Oleksi Petrenko. Cell ... von G Fingerle-Rowson · · Zitiert von: 48 — MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Günter Fingerle-Rowson &; Oleksi Petrenko. Cell ...

von C Schlander · — Günter Fingerle-Rowson gilt mein besonderer Dank für seine vielseiti- gen hilfreichen Ratschläge, den großzügig gewährten wissenschaftlichen ...

Privatdozent Dr. Günter Fingerle-Rowson, Klinik für Innere Medizin IKöln. Privatdozent Dr. Günter Fingerle-Rowson, Klinik für Innere Medizin IKöln.

8 Allgemeine Veröffentlichungen

Nic E. Savaskan | Günter Fingerle-Rowson | ... | Ilker Y. Eyüpoglu. 03 Sep 2012; PDFDownload PDF · CitationDownload citation.

von K Tobinai · · Zitiert von: 174 — Günter Fingerle-Rowson is an employee at F. Hoffmann-La Roche Ltd. and owns stock in F. Hoffmann-La Roche Ltd. Compliance with Ethics ... von K Tobinai · · Zitiert von: 174 — Günter Fingerle-Rowson is an employee at F. Hoffmann-La Roche Ltd. and owns stock in F. Hoffmann-La Roche Ltd. Compliance with Ethics ...

Günter Fingerle-Rowson Selected Research. Günter Fingerle-Rowson Research Topics. Disease. 4, Neoplasms (Cancer) , Rheumatoid Arthritis

Günter Fingerle-Rowson. No description defined. In more languages. Spanish. No label defined. No description defined. Traditional Chinese. No label defined.

3 Video- & Audioinhalte

— Günter Fingerle-Rowson, MD, CMO; Dr. Jonas Helma-Smets, CSO; Dr. Dominik Schumacher, CEO; Dr. Ingo Lehrke, CBO; Dr. Björn Hock, CDO ...

— Günter Fingerle-Rowson, Chief Medical Officer bei Tubulis. "Die neuartige P5-Technologie, die wir in TUB-040 verwenden, verbessert die — Günter Fingerle-Rowson, Chief Medical Officer bei Tubulis. "Die neuartige P5-Technologie, die wir in TUB-040 verwenden, verbessert die ...

— Günter Fingerle-Rowson, MD (CMO), Dr. Jonas Helma-Smets (CSO), Dr. Dominik Schumacher (CEO, Member of the Supervisory Board), Dr. Ingo — Günter Fingerle-Rowson, MD (CMO), Dr. Jonas Helma-Smets (CSO), Dr. Dominik Schumacher (CEO, Member of the Supervisory Board), Dr. Ingo ...

5 Meinungen & Artikel

von C Pott · · Zitiert von: 19 — Nathalie Spielewoy, Guenter Fingerle-Rowson, Kirsten Mundt & Elisabeth Wassner-Fritsch. Roche, Welwyn Garden City, UK. Chris Harbron.

— ... Günter Fingerle-Rowson, MD, PhD, Chief Medical Officer at Tubulis. "The novel P5 technology we use in TUB-040 improves upon current ...

vor 3 Tagen — ... Günter Fingerle-Rowson, MD, PhD, Chief Medical Officer at Tubulis. “Initiating our first clinical trial represents an important milestone ... vor 3 Tagen — ... Günter Fingerle-Rowson, MD, PhD, Chief Medical Officer at Tubulis. “Initiating our first clinical trial represents an important milestone ...

— Günter Fingerle-Rowson, MD (CMO), Dr. Jonas Helma-Smets (CSO), Dr. Dominik Schumacher (CEO, Mitglied des Aufsichtsrates), Dr. Ingo Lehrke (CBO) — Günter Fingerle-Rowson, MD (CMO), Dr. Jonas Helma-Smets (CSO), Dr. Dominik Schumacher (CEO, Mitglied des Aufsichtsrates), Dr. Ingo Lehrke (CBO) ...

125 Webfunde aus dem Netz

More Relevant Posts. View profile for Günter Fingerle-Rowson · Günter Fingerle-Rowson. Chief Medical Officer at Tubulis GmbH. 2w Edited. Report this post; Close ...

Günter Fingerle-Rowson's Post ... Tubulis is looking for an experienced clinical trial manager to run a phase I/II trial in solid tumors - are you interested in ...

Günter Fingerle-Rowson's Post. View profile for Günter Fingerle-Rowson, graphic · Günter Fingerle-Rowson. Chief Medical Officer at Tubulis GmbH. Günter Fingerle-Rowson's Post. View profile for Günter Fingerle-Rowson, graphic · Günter Fingerle-Rowson. Chief Medical Officer at Tubulis GmbH.

· Tubulis Clinical - Ines Vasconcelos (medical lead) and Günter Fingerle-Rowson (CMO) are at ESMO in Madrid....ADCs are taking off!

vor 2 Tagen — ... Günter Fingerle-Rowson, MD, PhD, Chief Medical Officer of Tubulis. "The FDA decision brings us one step closer to our goal of delivering the ... vor 2 Tagen — ... Günter Fingerle-Rowson, MD, PhD, Chief Medical Officer of Tubulis. "The FDA decision brings us one step closer to our goal of delivering the ...

WebArbeiten Sie bei der Firma Günter Fingerle-Rowson? Dann haben Sie die Möglichkeit diesen Firmeneintrag ganz einfach zu ergänzen oder zu aktualisieren. Ihr …

The groups of Associate Professor Günter Fingerle-Rowson and Dr Marco Herling work on the identification of new oncogenic signal transduction pathways in CLL ...

Guenter Fingerle-Rowson. Pharma Development, F. Hoffmann-La Roche Ltd. ( Basel, Switzerland). Odborné práce publikované na Linkos.cz. Přehled odborných textů ... Guenter Fingerle-Rowson. Pharma Development, F. Hoffmann-La Roche Ltd. ( Basel, Switzerland). Odborné práce publikované na Linkos.cz. Přehled odborných textů ...

Günter Fingerle-Rowson is the current CMO at Tubulis. Günter has also previously worked as an Associate Group Medical Director, Global Development Team ...

See what Günter Fingerle-Rowson (fingerlerowson) has discovered on Pinterest, the world's biggest collection of ideas. See what Günter Fingerle-Rowson (fingerlerowson) has discovered on Pinterest, the world's biggest collection of ideas.

Günter Fingerle-Rowson. fingerlerowson. ·. フォロワー：0 人. ·. フォロー中：0 人. フォロー. fingerlerowson さんはまだピンを保存していません.

WebMUNICH--(BUSINESS WIRE)-- Tubulis today announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership …

Tubulis today announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and to further build ...

Günter Fingerle-Rowson · この人物について · 関連論文 · 関連研究データ · 関連図書・雑誌 · 関連博士論文 · 関連プロジェクト · 関連その他成果物 · 詳細情報.

· Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs Business ...

· Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs. Published On: ...

Guenter Fingerle-Rowson · · Personal information · Activities. Guenter Fingerle-Rowson · · Personal information · Activities.

WebHerrn Privatdozent Dr. med. Günter Fingerle-Rowson Frau Dr. rer. nat. Tania Marina Brocks Herrn Dr. rer. nat. Oleg Fedorchenko Frau Dr. rer. nat. Romy Barthel Frau MTLA …

Web22 Apr · Tubulis stärkt klinische Expertise Dr. Günter Fingerle-Rowson ergänzt seit April als Chief Medical Officer das Management der Münchner Tubulis …

WebIn April 2021, industry leader Dr. Günter Fingerle-Rowson joined the team as Chief Medical Officer. His proven track record of advancing product candidates into clinical use, will …